国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2015年
8期
1072-1074
,共3页
膀胱癌%浸润性%保留膀胱手术%髂内动脉化疗%临床效果
膀胱癌%浸潤性%保留膀胱手術%髂內動脈化療%臨床效果
방광암%침윤성%보류방광수술%가내동맥화료%림상효과
Bladder cancer%Invasive%Bladder-preserving surgery%Internal iliac artery chemotherapy%Clinical efficacy
目的 探究分析对于浸润性膀胱癌患者采取保留膀胱手术联合髂内动脉化疗的临床治疗效果.方法 采用回顾性分析的方法,分析了我院2005年1月至2007年1月收治的116例浸润性膀胱癌患者的临床资料,根据治疗方法的不同,将本组患者随机分成对照组和实验组各58例,对照组患者给予保留膀胱手术治疗,实验组患者给予保留膀胱手术联合髂内动脉化疗.分析比较两组患者的临床治疗有效率和生存情况.结果 实验组患者的临床治疗有效率明显高于对照组,差异有统计学意义(89.66％ vs.72.41％;x2=4.54,P＜0.05);实验组患者的1年生存率、3年生存率和5年生存率明显高于对照组,差异有统计学意义(P＜0.05).结论 对于浸润性膀胱癌患者,给予其保留膀胱手术联合髂内动脉化疗的临床治疗效果较好,能够显著提高近期临床治疗有效率,同时提高1年、3年和5年的远期生存率,值得临床推广使用.
目的 探究分析對于浸潤性膀胱癌患者採取保留膀胱手術聯閤髂內動脈化療的臨床治療效果.方法 採用迴顧性分析的方法,分析瞭我院2005年1月至2007年1月收治的116例浸潤性膀胱癌患者的臨床資料,根據治療方法的不同,將本組患者隨機分成對照組和實驗組各58例,對照組患者給予保留膀胱手術治療,實驗組患者給予保留膀胱手術聯閤髂內動脈化療.分析比較兩組患者的臨床治療有效率和生存情況.結果 實驗組患者的臨床治療有效率明顯高于對照組,差異有統計學意義(89.66％ vs.72.41％;x2=4.54,P＜0.05);實驗組患者的1年生存率、3年生存率和5年生存率明顯高于對照組,差異有統計學意義(P＜0.05).結論 對于浸潤性膀胱癌患者,給予其保留膀胱手術聯閤髂內動脈化療的臨床治療效果較好,能夠顯著提高近期臨床治療有效率,同時提高1年、3年和5年的遠期生存率,值得臨床推廣使用.
목적 탐구분석대우침윤성방광암환자채취보류방광수술연합가내동맥화료적림상치료효과.방법 채용회고성분석적방법,분석료아원2005년1월지2007년1월수치적116례침윤성방광암환자적림상자료,근거치료방법적불동,장본조환자수궤분성대조조화실험조각58례,대조조환자급여보류방광수술치료,실험조환자급여보류방광수술연합가내동맥화료.분석비교량조환자적림상치료유효솔화생존정황.결과 실험조환자적림상치료유효솔명현고우대조조,차이유통계학의의(89.66％ vs.72.41％;x2=4.54,P＜0.05);실험조환자적1년생존솔、3년생존솔화5년생존솔명현고우대조조,차이유통계학의의(P＜0.05).결론 대우침윤성방광암환자,급여기보류방광수술연합가내동맥화료적림상치료효과교호,능구현저제고근기림상치료유효솔,동시제고1년、3년화5년적원기생존솔,치득림상추엄사용.
Objective To investigate the clinical efficacy of bladder-preserving surgery combined with internal iliac artery chemotherapy in the treatment of invasive bladder cancer.Methods Clinical data of 116 cases of invasive bladder cancer in our hospital from January 2005 to January 2007 was retrospectively analyzed.All patients were randomly divided into control group and experimental group according to treatment methods,58 cases in each group.Control group was treated with bladder-preserving surgery,while experimental group was treated with bladder-preserving surgery combined with internal iliac artery chemotherapy.Compared the clinical efficacy and survival situation of two groups.Results The treatment efficiency of experimental group was significantly higher than that of control group (89.66％ vs.72.41％;x 2=4.54,P＜0.05);1-year,3-year and 5-year survival rate of experimental group were significantly higher than those of control group (P＜0.05).Conclusions Bladder-preserving surgery combined with internal iliac artery chemotherapy in the treatment of invasive bladder cancer has good clinical efficacy,which can significantly improve short-term clinical treatment efficiency,1-year,3-year and 5-year survival rate,worthy of clinical application.
